Abstract
Selenoproteins, in which Se exists in the form of selenocysteine, are essential for protection against oxidative damage and cancer. Genetic data has provided evidence that reduced levels of these proteins, induced by loss of heterozygosity or chromosomal alterations [1], result in cellular oxidative stress as well as derangement of signaling cascades leading to inflammation, malignancy and progression. While several tumor species have been shown to be vulnerable, because of its high Se content and rich selenoprotein network, the thyroid is especially exposed to risk when intrathyroid Se content is low and Se intake is not appropriate. However, there is as yet insufficient evidence on whether Se supplementation via Se compounds and/or via fortification of food, achieves reduction in the risk of cancer, and more specifically that of thyroid cancer and whether Se is able of reducing aggression and tumor progression and whether increased availability of Se and its compounds is capable of lowering anticancer drug toxicity and drug resistance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zhuo P, Diamond AM (2009) Biochim Biophys Acta 1790: 1546
Böck A, Forchhammer K, Heider J, Leinfelder W, Sawers G, Veprek B, Zinoni F (1991) Mol Microbiol 5: 515
Beckett GJ, Arthur JR (2005) J Endocrinol 184: 455
Steinbrenner H, Sies H (2009) Biochim Biophys Acta 1790: 1478
Brigelius-Flohé R (2008) Chem Biodivers 5: 389
Meuillet E, Stratton S, Prasad Cherukuri D (2004) J Cell Biochem 91: 443
Ganther HE (1999) Carcinogenesis 20: 1657
Ip C, Ganther H (1990) Cancer Res 50: 1206
Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. (1996) JAMA 276: 1957
Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, et al. (2003) Br J Urol 91: 608
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2004) Lancet 364: 1219
Yu SY, Zhu YJ, Li WG (1997) Biol Trace Elem Res 56: 117
Li B, Taylor PR, Li JY, et al. (1993) Ann Epidemiol 3: 577
Patrick L (2004) Altern Med Rev 9: 239
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. (2009) JAMA 301: 39
Hatfield DL, Gladyshev VN (2009) Mol Interv 9: 18
Rayman MP (2005) Proc Nutr Soc 64: 527
Ip C (1998) J Nutr 128: 1845
Kellen E, Zeegers M, Buntinx F (2006) Int J Urol 13: 1180
Combs GF Jr, Gray WP (1998) Pharmacol Ther 79: 179
Lu J, Berndt C, Holmgren A (2009) Biochim Biophys Acta 1790: 1513
Diwadkar-Navsariwala V, Prins GS, Swanson SM, Birch LA, Ray VH, Hedayat S, et al. (2006) Proc Natl Acad Sci USA 103: 8179
Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2002) Biol Trace Elem Res 88: 25
Apostolou S, Klein JO, Mitsuuchi Y, Shetler JN, Poulikakos PI, Jhanwar SC, Kruger WD, Testa JR (2004) Oncogene 23: 5032
Selenius M, Fernandes AP, Brodin O, Bjönnstedt M, Rundlöf AK (2008) Biochem Pharmacol 75: 2092
Meplan C, Nicol F, Burtle B, Crosley L, Arthur J, Mathers J, Hesketh J (2009) Antioxid Redox Signal 11: 2631
Burk RF, Hill KE (2005) Ann Rev Nutr 25: 215
Koehrle J (2000) Cell Mol Life Sci 57: 1853
Koehrle J, Jakob B, Contempre B, Dumont JE (2005) Endocr Rev 26: 944
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Science 179: 588
Schomburg L, Koehrle J (2008) Mol Nutr Food Res 52: 1235
Schmutzler C, Mentrup B, Schomburg L, Huang-Vu, et al. (2007) Biol Chem 388: 1053
Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN (2003) Science 300: 1439
Contempre B, Dumont JE, Denef JF, Many MC (1995) Eur J Endocrinol 133: 99
Corvilain B, Contempre B, Longombe AO, Goyens P, Gervy-Decoster C, Lamy F, et al. (1993) Am J Clin Nutr 57: 244S
Namba H, Gutman RA, Matsuo K, Alvarez A, Fagin JA (1990) J Clin Endocrinol Metab 71: 223
Krohn K, Maier J, Paschke R (2007) Nat Clin Pract Endocrinol Metab 31: 713
Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H (1993) Sci Total Environ 139–140: 527
Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J (1989) Int J Epidemiol 18: 45
Foster HD (1993) Med Hypotheses 40: 61
Duntas LH (2006) Thyroid 16: 455
Knobel M, Medeiros-Neto G (2007) Arq Bras Endocrinol Metab 51: 701
Pufnock JS, Rothstein JL (2009) J Immunol 182: 5498
Duntas LH (2009) Horm Metab Res 41: 1
Ravasco P, Aranha MM, Borralho PM, Moreira da Silva IB, Correia L, Fernandes A, Rodrigues CM,Camilo M (2010) Clin Nutr 29: 42
Burk RF, Hill KE, Nakayama A, Mostert V, Levander XA, Motley AK, et al. (2008) Free Radic Biol Med 44: 1617
Zeng H, Wu M, Botnen JH (2009) J Nutr 139: 1613
Gundimeda U, Schiffman JE, Gottlieb SN, Roth B, Gopalakrishna R (2009) Carcinogenesis 30: 1553
Karunasinghe N, Ryan j, Tuckey J, Masters J, Jamieson M, Clarke LC, et al. (2004) Epidemiology Biomarkers and Prevention 13: 391
Jackson MI, Combs GF Jr. (2008) Curr Opin Clin Nutr Metab Care]_11: 718
Zeng H, Combs GF Jr. (2008) J Nutr Biochem 19: 1
Fischer J, Mihelc EM, Pollok KE, Smith ML (2007) Mol Cancer Ther 6: 355
Rigobello MP, Gandin V, Folda A, Rundlof AK, Fernandes AP, Bindoli A, et al. (2009) Free Radic Biol Med 47: 710
Fakih M, Cao S, Durrani FA, Rustum YM (2005) Clin Colorectal Cancer 5: 132
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Zhejiang University Press, Hangzhou and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Duntas, L.H., Smyth, P.P.A. (2011). Selenoproteins and Thyroid Cancer. In: Selenoproteins and Mimics. Advanced Topics in Science and Technology in China. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22236-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-22236-8_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-22235-1
Online ISBN: 978-3-642-22236-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)